Targeting PGLYRP1 in cancer and autoimmunity
Nature Immunology - Immune checkpoint inhibitors provide beneficial anti-tumor immunity but risk immune-related adverse events occurring in normal tissues. Notably, selective deletion of PGLYRP1, a...
nature.com